SNOA - Sonoma Pharmaceuticals, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
Sonoma Pharmaceuticals, Inc.
Sonoma Pharmaceuticals Inc is engaged in developing and commercializing differentiated therapies to patients living with chronic skin conditions. It develops solutions in to treat skin conditions, such as acne, atopic dermatitis, and scarring.
IPO Date: February 1, 2007
Sector: Healthcare
Industry: Pharma
Market Cap: $5.84M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.16 | 4.35%
Avg Daily Range (30 D): $0.03 | 2.30%
Avg Daily Range (90 D): $0.04 | 3.14%
Institutional Daily Volume
Avg Daily Volume: .64M
Avg Daily Volume (30 D): .05M
Avg Daily Volume (90 D): .11M
Trade Size
Avg Trade Size (Sh.): 249
Avg Trade Size (Sh.) (30 D): 285
Avg Trade Size (Sh.) (90 D): 251
Institutional Trades
Total Institutional Trades: 16
Avg Institutional Trade: $.93M
Avg Institutional Trade (30 D): $.6M
Avg Institutional Trade (90 D): $.6M
Avg Institutional Trade Volume: .02M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $M
Avg Closing Trade (30 D): $M
Avg Closing Trade (90 D): $M
Avg Closing Volume: K
 
News
Jul 12, 2024 @ 9:35 AM
Why Ericsson Shares Are Trading Higher; Here Are 2...
Source: Avi Kapoor
Jun 28, 2024 @ 12:50 PM
Sonoma Pharmaceuticals (SNOA) Shows Fast-paced Mom...
Source: Zacks Equity Research
Jan 24, 2024 @ 1:14 PM
Why Netflix Shares Are Trading Higher By 10%; Here...
Source: Avi Kapoor
Dec 18, 2023 @ 6:05 PM
Why Lantheus Holdings Shares Are Trading Lower By ...
Source: Avi Kapoor
Dec 18, 2023 @ 1:10 PM
Why Arcutis Biotherapeutics Shares Are Trading Hig...
Source: Avi Kapoor
Financials
  TTM Q4 2026 FY 2026
Basic EPS $-.09 $-.33 $-1.89
Diluted EPS $-.09 $-.33 $-1.89
Revenue $6.41M $5.56M $19.53M
Gross Profit $2.58M $2.18M $7.42M
Net Income / Loss $-.33M $-.58M $-3.18M
Operating Income / Loss $-.04M $-.35M $-2.46M
Cost of Revenue $3.83M $3.38M $12.11M
Net Cash Flow $2.94M $-.16M $-2.98M
PE Ratio    
Splits
Aug 30, 2024 1:20
Jun 20, 2019 1:9
Jun 27, 2016 1:5
Apr 01, 2013 1:7